Boris Gorelik

Boris Gorelik has held various roles and positions in different companies throughout their career. Boris started as an intern at Goldfarb, Levy, Eran & Co. in 2006 and later joined KPMG Advisory as a Senior Associate in 2007, where they provided financial advisory services, conducted commercial due diligence, and worked on financial modeling. In 2010, they joined Deloitte as a Manager in Transaction Services and held that position until 2013. From 2013 to 2020, they worked at Teva Pharmaceutical Industries Ltd. as a Senior Director in Global Business Development & Strategy. In 2018, Boris became the Chief Financial Officer at Nextgen Biomed (TASE:NXGN), a position they held until 2019. Currently, they are working at KAMADA, where they started as the Director of Business Development in April 2020 and is now the Vice President of Business Development and Strategic Programs since June 2022.

Boris Gorelik completed an LLB degree in Law from Tel Aviv University between 2002 and 2006. Boris also pursued a degree in Accounting from the same university during the same time period. Later, in 2008 and 2009, they obtained an MBA degree in Business from Tel Aviv University.